Litcius/Paper detail

Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(<scp>iii</scp>)-based complexes with functionalized α-lipoic acid

Mengmeng Wang, Xuling Xue, Xi-Xi Sheng, Yan Su, Yaqiong Kong, Yong Qian, Jianchun Bao, Zhi Su, Hong‐Ke Liu

2020RSC Advances27 citationsDOIOpen Access PDF

Abstract

) demonstrated that introduction of the LA ligand to Ir2 could highly enhance the cytotoxicity and help to overcome the cisplatin-resistance. This study of the half-sandwich and cyclometalated Ir(iii)-based anticancer agents highlighted the different MoAs toward cancer cells and provided new insights for understanding their structure-property relationships.

Topics & Concepts

Mechanism (biology)Lipoic acidCancerChemistryCombinatorial chemistryBiochemistryMedicinePhysicsInternal medicineAntioxidantQuantum mechanicsBiochemical Acid Research Studiesbiodegradable polymer synthesis and propertiesCarbon dioxide utilization in catalysis
Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(<scp>iii</scp>)-based complexes with functionalized α-lipoic acid | Litcius